Literature DB >> 7818998

What are the clinical uses of insulin-like growth factor-I in acute and chronic renal failure?

M R Hammerman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818998     DOI: 10.1007/bf00858121

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  8 in total

1.  Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.

Authors:  H Ding; J D Kopple; A Cohen; R Hirschberg
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

2.  The acute effect of growth hormone on GFR is obliterated in chronic renal failure.

Authors:  D Haffner; S Zacharewicz; O Mehls; U Heinrich; E Ritz
Journal:  Clin Nephrol       Date:  1989-12       Impact factor: 0.975

3.  Effects of IGF-I on renal function in patients with chronic renal failure.

Authors:  M H O'Shea; S B Miller; M R Hammerman
Journal:  Am J Physiol       Date:  1993-05

4.  Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis.

Authors:  T R Ziegler; J M Lazarus; L S Young; R Hakim; D W Wilmore
Journal:  J Am Soc Nephrol       Date:  1991-12       Impact factor: 10.121

5.  Effects of IGF-I on renal function in end-stage chronic renal failure.

Authors:  S B Miller; M Moulton; M O'Shea; M R Hammerman
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

6.  Rat models for clinical use of insulin-like growth factor I in acute renal failure.

Authors:  S B Miller; D R Martin; J Kissane; M R Hammerman
Journal:  Am J Physiol       Date:  1994-06

Review 7.  Growth hormone and the kidney: a case presentation and review of the literature.

Authors:  M H O'Shea; D T Layish
Journal:  J Am Soc Nephrol       Date:  1992-08       Impact factor: 10.121

8.  Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat.

Authors:  S B Miller; D R Martin; J Kissane; M R Hammerman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.